CD4 and type 2 diabetes mellitus: Comparing FWLH and IWLH with linear regression models, we did not evidence any difference in rate of HIV RNA undetectability, type of antiretroviral therapies, CD4+ cell count, prevalence of comorbidities (chronic kidney disease, bone disease, dyslipidaemia, type 2 diabetes mellitus, hypertension, and hypothyroidism), concomitant medications, annual weight gain, or access to multidimensional geriatric assessment.